MAP2K7 and neoplasm: Antiprogestin treatment dramatically inhibits BT-474 tumor growth in xenograft models [70] and significantly blocks BT-474 cell proliferation in MTT assays conducted over six days in vitro; similar results were observed with the MEK inhibitor, U0126 (data not shown).